Clinical Trials Intelligence — ClinicalTrials.gov + AI avatar

Clinical Trials Intelligence — ClinicalTrials.gov + AI

Pricing

from $66.00 / 1,000 query analyzeds

Go to Apify Store
Clinical Trials Intelligence — ClinicalTrials.gov + AI

Clinical Trials Intelligence — ClinicalTrials.gov + AI

Search clinical trials from the official ClinicalTrials.gov registry. Give it conditions, drugs or keywords; get back trial status, phases, sponsors and eligibility.

Pricing

from $66.00 / 1,000 query analyzeds

Rating

0.0

(0)

Developer

Fredrik Hansson

Fredrik Hansson

Maintained by Community

Actor stats

0

Bookmarked

2

Total users

1

Monthly active users

12 hours ago

Last modified

Features

Limited permissions

Share

Turn any drug, disease or sponsor into a read on the clinical pipeline. Give it a condition (glioblastoma), a drug (semaglutide) or a company (Moderna) and this Actor searches the official ClinicalTrials.gov registry, pulls every matching trial — phase, status, enrollment, sponsor, interventions — and uses OpenAI to summarise the research landscape: who's leading, where the pipeline sits, which trials matter, and what's emerging.

You bring a search term. It hands back a structured trial table plus an analyst's one-page read.


The flow

1. You give a query 2. ClinicalTrials.gov API v2 3. Get trials + an AI landscape
condition · drug · sponsor → (official registry, free, → phases · status · sponsors ·
· keyword no key) enrollment · AI summary
  1. You give one or more queries — conditions, drugs, sponsors or keywords.
  2. The Actor queries ClinicalTrials.gov (the official U.S. registry) via its public v2 API, sorted by most-recently-updated, optionally filtered by recruitment status.
  3. You get back one record per trial, plus a landscape record per query with aggregate metrics and an AI read of the research field.

What you get per query

For every query the Actor:

  1. Pulls matching trials from ClinicalTrials.gov (up to maxTrialsPerQuery), each mapped to: nctId, title, overallStatus, phases, studyType, enrollment, leadSponsor, conditions, interventions, startDate, completionDate, and a direct url.
  2. Aggregates the set into totalTrials (registry-wide count), phaseDistribution, statusDistribution, topSponsors and recruitingCount.
  3. Runs one AI pass (OpenAI gpt-4o-mini, a fast and low-cost model) over the trial set to produce:
    • landscapeSummary — 2-3 sentences on the overall state of research for the query.
    • activePhaseFocus — one sentence on where the pipeline sits across phases.
    • leadingSponsors — the most active sponsors.
    • emergingInterventions — drug / approach names seen across the trials.
    • notableTrials — 3-6 standout trials, each with { nctId, title, phase, sponsor, why }.
    • signalForInvestors — one neutral, grounded sentence on research momentum.

The AI is grounded only in the trials pulled — it never invents NCT ids, sponsors or phases.

Not medical or financial advice. This Actor surfaces and summarises public registry data for research and business-intelligence purposes. Nothing it outputs is clinical guidance or an investment recommendation.


Three ways people use it

  • Pharma / biotech competitive intelligence — track a competitor's drug pipeline, watch a disease area fill with trials, and see which sponsors own which phases. A living clinical trials API feed for your BD and strategy teams, built on ClinicalTrials.gov.
  • Investor / BD due diligence — before a deal or a thesis, pull every trial for an asset or an indication, read the phase mix and the enrollment, and get a grounded landscape summary — biotech intelligence without a Bloomberg terminal.
  • Clinical research monitoring — CROs, sites and med-affairs teams run standing trial monitoring on conditions and interventions to catch new recruiting studies, terminations and completions the moment the registry updates.

Keywords this covers: clinical trials API, ClinicalTrials.gov, drug pipeline, biotech intelligence, trial monitoring.


Input

FieldTypeNotes
queriesarrayRequired. Conditions, drugs, sponsors or keywords. One per line.
statusFilterarrayOptional. Only return trials in these statuses: RECRUITING, ACTIVE_NOT_RECRUITING, COMPLETED, TERMINATED. Omit for all.
maxTrialsPerQueryintegerTrials to pull per query. Default 25.
maxResultsintegerCap how many queries to process. Default 100.
maxConcurrencyintegerQueries processed in parallel. Default 3.
modelstringOverride the OpenAI model. Default gpt-4o-mini.

Minimal input example

{
"queries": ["glioblastoma", "semaglutide", "Moderna"],
"maxTrialsPerQuery": 25
}

Output example

A trial record (one per trial):

{
"query": "glioblastoma",
"recordType": "trial",
"nctId": "NCT07862647",
"title": "TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma",
"overallStatus": "RECRUITING",
"phases": ["PHASE1"],
"studyType": "INTERVENTIONAL",
"enrollment": 30,
"leadSponsor": "Alpheus Medical, Inc.",
"conditions": ["Glioblastoma", "GBM", "Butterfly GBM"],
"interventions": [
{ "type": "DRUG", "name": "5-ALA" },
{ "type": "DEVICE", "name": "LIDU ultrasound" }
],
"startDate": "2026-10-29",
"completionDate": "2028-03-30",
"url": "https://clinicaltrials.gov/study/NCT07862647"
}

A landscape record (one per query):

{
"query": "glioblastoma",
"recordType": "landscape",
"totalTrials": 2468,
"phaseDistribution": { "PHASE1": 9, "PHASE2": 11, "PHASE3": 2, "NA": 3 },
"statusDistribution": { "RECRUITING": 14, "COMPLETED": 7, "TERMINATED": 1 },
"topSponsors": [
{ "name": "National Cancer Institute (NCI)", "count": 3 },
{ "name": "Alpheus Medical, Inc.", "count": 1 }
],
"recruitingCount": 14,
"landscapeSummary": "Glioblastoma research remains highly active, dominated by early-phase interventional trials testing novel drug-device and immunotherapy combinations alongside standard temozolomide + radiotherapy.",
"activePhaseFocus": "The pipeline sits mostly in Phase 1/2, with few Phase 3 confirmatory studies.",
"leadingSponsors": ["National Cancer Institute (NCI)", "Alpheus Medical, Inc."],
"emergingInterventions": ["5-ALA sonodynamic therapy", "CAR-T", "oncolytic virus"],
"notableTrials": [
{ "nctId": "NCT07862647", "title": "TMZ + RT + 5-ALA + LIDU SDT", "phase": "PHASE1", "sponsor": "Alpheus Medical, Inc.", "why": "Novel sonodynamic drug-device approach for inoperable butterfly GBM." }
],
"signalForInvestors": "Momentum is concentrated in early-phase novel modalities rather than late-stage confirmatory trials; not medical or financial advice."
}

Pay-per-event pricing

This Actor uses pay-per-event billing with a single event:

EventCharged whenPrice
query-analyzedOnce per condition/drug/sponsor searched across ClinicalTrials.gov and summarized with AI.$0.15

The Actor logs its OpenAI token usage and the estimated AI cost at the end of every run, so the event price always stays safely above the model cost.


Data source

Data comes from the official ClinicalTrials.gov registry via its public API v2 — a free, U.S. National Library of Medicine service listing publicly and privately supported clinical studies worldwide. No registry key is required.


Setup

The AI layer calls the OpenAI API. Set the environment variable / secret OPENAI_API_KEY on the Actor. Without it, the run stops before processing — the AI landscape read is core to the output.


Use it from an AI agent (Apify MCP server)

This Actor is available through the Apify MCP server, so AI agents (Claude, ChatGPT, or anything that speaks MCP) can call it as a tool — hand it a list of queries, and read back the trials and landscape — with no custom integration code.


Run it locally

npm install
# put your input in storage/key_value_stores/default/INPUT.json
export OPENAI_API_KEY=sk-...
apify run -p


Part of the No Niner toolkit — no-code web scraping, enrichment & AI data tools, all pay-per-use. Browse the full set at noniner.io.